Recent
- Tryp Therapeutics Has Completed Psychotherapist Training for a Planned Clinical Trial to Investigate Psilocybin Therapy for IBS
- Psychedelic Business Spotlight – July 1
- Psychedelic Business Spotlight – April 29
- Psychedelic Business Spotlight – December 24
- FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating Disorder
- Psychedelic Business Spotlight: November 5
- Psychedelic Business Spotlight: August 13, 2021
- Psychedelic Business Spotlight: July 9, 2021
Tryp Therapeutics
Public Company
[stockdio-historical-chart symbol="TRYP.CN" stockExchange="" palette="financial-light"]
